The story of Viagra, and its developer copyright, presents a intriguing case study for investors. At first a blockbuster drug, generating billions in revenue , its patent expiration created a wave of generic competition , significantly eroding its dominance. While specific businesses may attempt to capitalize on male sexual dysfunction, the current